Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Azithromycin Action Pathway
Homo sapiens
Drug Action Pathway
Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration. It is commonly administered via oral consumption and diffuses throughout the body. It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. Like other macrolide antimicrobials, azithromycin binds to the 23S portion of the 50S bacterial ribosomal subunit. It inhibits bacterial protein synthesis by preventing the addition of aminoacyl-tRNA to the growing protein through the ribosome. Inhibition of protein synthesis leads to apoptosis of the bacteria since essential proteins required for the bacteria to survive are not being produced.
References
Azithromycin Pathway References
Sandman Z, Iqbal OA: Azithromycin.
Pubmed: 32491698
Ng LK, Martin I, Liu G, Bryden L: Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2002 Sep;46(9):3020-5. doi: 10.1128/AAC.46.9.3020-3025.2002.
Pubmed: 12183262
Pereyre S, Renaudin H, Charron A, Bebear C, Bebear CM: Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin. J Antimicrob Chemother. 2006 Apr;57(4):753-6. doi: 10.1093/jac/dkl026. Epub 2006 Feb 7.
Pubmed: 16464889
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
No Proteins Present
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
No Proteins Present
Clear
Downloads
Settings